This conclusion was further supported by Gogola-Mruk et al. in ovarian cancer spheroids, where the authors were able to show that visfatin, another name for NAMPT, increased ATP levels and mitochondrial activity, while its inhibition with FK866 reversed these effects [153]. The gene discussed is NAMPT; the disease is ovarian carcinoma.